-
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies
Veenstra, C. R., Ngai, L. L., Gradowska, P., Versluis, J., Reuvekamp, T., Kelder, A., Scholten, W., Snel, S., Tettero, J. M., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Griskevicius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R. & Porkka, K. & 7 others, , May 2026, In: HemaSphere. 10, 5, e70379.Research output: Contribution to journal › Article › Academic › peer-review
-
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
Haaksma, L. H., Palmieri, R., Reuvekamp, T., Tettero, J. M., Ngai, L. L., Bachas, C., Kelder, A., Scholten, W. J., Gradowska, P., Arena, V., João Simione, A., Maurillo, L., Venditti, A., Löwenberg, B., Ossenkoppele, G. J., de Leeuw, D. C., Ikoma-Colturato, M. R. V., Buccisano, F. & Cloos, J., 10 Dec 2025, (E-pub ahead of print) In: Leukemia.Research output: Contribution to journal › Article › Academic › peer-review
-
Measurable residual disease monitoring in acute myeloid leukaemia: Techniques, timing and therapeutic implications
Croese, K. J., Cloos, J. & Tettero, J. M., Jun 2025, In: Seminars in Hematology. 62, 3, p. 167-176 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
